what happens if you double dose semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products GLP-1 Drug Overdose

In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol

Belonging to a class known as aldosterone antagonists, it works by balancing certain hormones in the body

For patients using the medication to treat acne, there may be a temporary worsening of skin conditions - a "purging" phase - before improvement is typically seen around the three-month mark

Perioperative management of long-acting glucagon-like peptide-1 receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration

Obesity is a chronic condition, and your prescription medication is a tool for long-term management